PharmaCell

Activities: Research & Development Pharmaceutical

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Media

Lonza acquires cell and gene contract manufacturer PharmaCell

Lonza successfully completed the acquisition of PharmaCell B.V., one of the most successful cell and gene contract manufacturers in Europe
Finance

Orchard Therapeutics Ltd. announces a manufacturing alliance with PharmaCell B.V.

Orchard Therapeutics, a clinical-stage biotechnology company dedicated to bringing transformative ex-vivo gene therapies to patients with serious and life-threatening orphan diseases announces today an alliance with PharmaCell B.V., a leading Contract Manufacturing Organization (CMO) for Cell and Gene Therapies and Regenerative Medicine.
Manufacturing

TiGenix to sell Dutch manufacturing facility to PharmaCell

Facility will continue to manufacture cell therapy cartilage regeneration treatment ChondroCelect for TiGenix
Manufacturing

Merck Millipore and PharmaCell to accelerate commercialisation of safe stem cell therapies

Will evaluate Mobius bioreactor platform for expansion of HepaRG cells
Subscribe now